Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients

BACKGROUND: Malnutrition, weight loss, and muscle wasting (sarcopenia) are common among women with advanced ovarian cancer and have been associated with adverse clinical outcomes and survival. Our objective is to investigate overall survival (OS) related to changes in skeletal muscle (SM) for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutten, Iris J.G., van Dijk, David P.J., Kruitwagen, Roy F.P.M., Beets‐Tan, Regina G.H., Olde Damink, Steven W.M., van Gorp, Toon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782251/
https://www.ncbi.nlm.nih.gov/pubmed/27030813
http://dx.doi.org/10.1002/jcsm.12107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782251/
https://www.ncbi.nlm.nih.gov/pubmed/27030813
http://dx.doi.org/10.1002/jcsm.12107

Ejemplares similares